Governance Daiichi Sankyo Company, Limited

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 07:30:00 11/07/2025 BST			5-day change	1st Jan Change
3,258.00 ^JPY	+1.50%		+0.99%	-25.14%

07-09	Turalio Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of Enliven Phase 3 Trial	CI
07-01	Tranche Update on Daiichi Sankyo Company, Limited's Equity Buyback Plan announced on April 25, 2025.	CI

Executive Committee: Daiichi Sankyo Company, Limited

Manager

Positions heldSince

Hiroyuki Okuzawa

61 year

Chief Executive Officer	31/03/2025
President	31/03/2024

Kenji Sato

62 year

Comptroller/Controller/Auditor

31/05/2019

Tomohiro Kodama

Comptroller/Controller/Auditor	-
Investor Relations Contact	-

Akio Sakurai

Sales & Marketing

Takashi Matsumoto

61 year

Human Resources Officer

31/03/2019

Composition of the Board of Directors: Daiichi Sankyo Company, Limited

Director

CommitteesSince

Sunao Manabe

70 year

Chairman

31/03/2023

Sawako Nohara

67 year

Nominating Committee	31/05/2021
Compensation Committee Chair	31/05/2019
Compensation Committee	31/05/2021

Kazuaki Kama

76 year

Nominating Committee Chair	31/05/2019
Audit Committee	31/05/2023
Compensation Committee Chair	31/05/2023

Reiko Kinoshita

61 year

Director/Board Member

22/06/2025

Akihiro Watanabe

66 year

Director/Board Member

22/06/2025

Kenneth Joseph Keller

62 year

Director/Board Member

22/06/2025

Yo Honma

69 year

Director/Board Member	16/06/2024
Independent Dir/Board Member	16/06/2024

Takaaki Nishii

65 year

Director/Board Member	31/05/2023
Independent Dir/Board Member	31/05/2023

Takashi Matsumoto

61 year

Director/Board Member

16/06/2024

Takashi Fukuoka

64 year

Director/Board Member

31/05/2022

Yasuhiro Komatsu

67 year

Director/Board Member	31/05/2022
Independent Dir/Board Member	31/05/2022

Hiroyuki Okuzawa

61 year

Director/Board Member

20/06/2021

Latest Appointments: Daiichi Sankyo Company, Limited

Immuneering Names Dr. Igor Matushansky, MD, PhD, as Chief Medical Officer	03-20	CI
Daiichi Sankyo Names CEO	02-02	MT
Daiichi Sankyo Company, Limited Announces Chief Executive Officer Changes, Effective April 1, 2025	01-31	CI
Daiichi Sankyo Company, Limited Announces Executive Changes	12-15	CI
Daiichi Sankyo Company, Limited Announces Retirement of Noritaka Uji, Outside Director	16/05/23	CI
Daiichi Sankyo Posts 8% Decline in Fiscal Nine-month Attributable Profit on Growing Expenses; Rejigs Management Structure	01/02/23	MT

More news

Former Officers and Directors: Daiichi Sankyo Company, Limited

Insider

Positions held

SinceUntil

Toshiaki Sai

Director/Board Member	31/05/2015	20/06/2021
Director of Finance/CFO	31/05/2018	20/06/2021
Investor Relations Contact	-	-
Public Communications Contact	31/03/2008	31/05/2014
Corporate Officer/Principal	31/03/2012	31/05/2018

Toshiaki Tojo

Director/Board Member	31/05/2016	14/06/2020
Corporate Officer/Principal	31/03/2010	14/06/2020

Joji Nakayama

Director/Board Member	31/05/2010	31/03/2017
Chief Executive Officer	31/05/2010	31/05/2019
Chairman	31/03/2017	14/06/2020
President	31/05/2010	31/03/2017

Kazunori Hirokawa

Chief Administrative Officer	31/03/2015	17/06/2018
Director/Board Member	31/05/2010	17/06/2018
Chief Tech/Sci/R&D Officer	31/03/2007	31/03/2012
Corporate Officer/Principal	31/03/2012	31/03/2015

Shuji Handa

Corporate Officer/Principal

31/03/2017

Norimasa Kamura

Human Resources Officer

31/03/2017

Takeshi Ogita

Director/Board Member	31/05/2009	19/06/2016
Chief Tech/Sci/R&D Officer	31/03/2010	31/03/2014
Human Resources Officer	31/03/2009	31/03/2014
Corporate Officer/Principal	31/03/2014	31/03/2016
Sales & Marketing	07/10/2010	31/03/2014

Yuki Sato

Director/Board Member	31/05/2011	19/06/2016
Human Resources Officer	31/03/2014	31/03/2016
General Counsel	31/03/2014	31/03/2015
Corporate Officer/Principal	31/03/2007	31/05/2014

Manabu Sakai

Chief Administrative Officer	31/05/2014	21/06/2015
Director/Board Member	31/05/2014	21/06/2015
Director of Finance/CFO	07/10/2010	23/01/2012
Corporate Officer/Principal	23/01/2012	31/05/2014

Kazuo Koike

Comptroller/Controller/Auditor

03/07/2011

21/06/2015

Kunio Ishihara

Director/Board Member

07/10/2010

21/06/2015

Takashi Chiba

Comptroller/Controller/Auditor

03/07/2011

21/06/2015

Hiroshi Hirabayashi

Director/Board Member

07/10/2010

21/06/2015

Noritaka Uji

Director/Board Member	31/05/2014	14/06/2020
Chairman	14/06/2020	-
Independent Dir/Board Member	31/05/2014	-

Hiroshi Toda

Director/Board Member	31/05/2014	-
Independent Dir/Board Member	31/05/2014	-

Takashi Okimoto

Director/Board Member

05/01/2010

31/05/2012

Toru Kuroda

Corporate Officer/Principal

31/12/1999

31/05/2011

Jotaro Yabe

Director/Board Member

05/01/2010

27/06/2010

Kunio Nihira

Director/Board Member

05/01/2010

27/06/2010

Ryuzo Takada

Director/Board Member	05/01/2010	27/06/2010
Corporate Officer/Principal	05/01/2010	-
Sales & Marketing	05/01/2010	27/06/2010

Yuichiro Anzai

Director/Board Member

07/10/2010

Kiyoshi Morita

Chairman

05/01/2010

27/06/2010

Yoshifumi Nishikawa

Director/Board Member

05/01/2010

27/06/2010

Satoru Kimura

Director/Board Member	31/05/2019	-
Corporate Officer/Principal	20/06/2021	-
Sales & Marketing	31/03/2014	20/06/2021

Francis Plat

Corporate Officer/Principal

31/12/2004

31/12/2008

Katsumi Fujimoto

Director/Board Member	31/05/2016	-
Corporate Officer/Principal	31/03/2007	31/03/2019

Hideyuki Haruyama

Comptroller/Controller/Auditor	31/05/2015	-
Corporate Officer/Principal	31/03/2007	31/05/2015

Hitoshi Matsuda

Director/Board Member

05/01/2010

Akira Nagano

Public Communications Contact	23/01/2012	-
Corporate Officer/Principal	07/10/2010	23/01/2012

Ryoichi Watanabe

Comptroller/Controller/Auditor	31/03/2007	-
Director of Finance/CFO	31/03/2009	31/03/2015
Investor Relations Contact	31/03/2007	31/03/2016

Kazuyuki Watanabe

Comptroller/Controller/Auditor	31/05/2015	-
Public Communications Contact	31/05/2014	31/05/2015

Teruo Takayanagi

Comptroller/Controller/Auditor

05/01/2010

Hikaru Nagata

Comptroller/Controller/Auditor

07/10/2010

Tsutomu Une

Director/Board Member	03/07/2011	-
Corporate Officer/Principal	03/07/2011	29/04/2012

Takashi Shoda

Chairman	07/10/2010	-
Corporate Officer/Principal	07/10/2010	07/10/2010
President	25/05/2009	07/10/2010

Keiji Sawamukai

Corporate Officer/Principal

31/12/2000

Junichi Koga

Chief Tech/Sci/R&D Officer	-	31/03/2019
Corporate Officer/Principal	-	-

Kenji Inoue

Sales & Marketing

31/05/2014

Ryoji Nagasaka

Corporate Officer/Principal	-	31/03/2016
Corporate Secretary	31/03/2015	-

Kazuhiko Tanzawa

Corporate Officer/Principal

07/10/2010

Seiji Sugiyama

Director/Board Member

Audrey L. Hill

Corporate Officer/Principal

Ichiro Kanazawa

Director/Board Member

Shinichi Terano

Corporate Officer/Principal	03/07/2011	23/01/2012
Sales & Marketing	-	-

Katsuaki Miyoshi

Corporate Officer/Principal	03/07/2011	23/01/2012
Sales & Marketing	07/10/2010	-

Noriaki Ishida

Public Communications Contact	31/05/2014	-
Corporate Officer/Principal	07/10/2010	31/05/2014

Tomoo Yokoi

Comptroller/Controller/Auditor	07/10/2010	-
Director of Finance/CFO	07/10/2010	-
Corporate Officer/Principal	07/10/2010	07/10/2010

Haruhisa Kubota

Corporate Officer/Principal

07/10/2010

Ryoichi Kibushi

Sales & Marketing

07/10/2010

Kyohei Nonose

Human Resources Officer	07/10/2010	23/01/2012
Corporate Officer/Principal	23/01/2012	-

Glenn Gormley

Chief Tech/Sci/R&D Officer	-	30/03/2019
Corporate Officer/Principal	31/03/2019	-

Yoshikazu Takano

Chief Administrative Officer	23/01/2012	-
Public Communications Contact	07/10/2010	23/01/2012

Dalton Einhorn

Corporate Officer/Principal

Jeff Halperin

Corporate Officer/Principal

Satoshi Kunitada

Corporate Officer/Principal

07/10/2010

Age distribution of managers

Parity Men Women

Male	14
Female	2

Of which Executive Committee

Male	5
Female	0

Of which Directors

Male	10
Female	2

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

AAA

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Employees

19,765

Sector

Pharmaceuticals

Calendar

07-30 - Q1 2025 Earnings Release

More about the company